col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


60 Results       Page 1

 [1] 
Elsevier: Pathology
  original article Date Title Authors   All Authors
1 [GO] 2022―Apr―21 Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput Thuy Phan, Ngoc Yen Kim Tran, Thomas Gottlieb, Steven Siarakas, Genevieve McKew
2 [GO] 2022―Apr―16 SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability Charles S.P. Foster, Mathew Madden, Raymond Chan, David Agapiou, Rowena A. Bull, William D. Rawlinson, Sebastiaan J. Van Hal
3 [GO] 2022―Apr―16 SARS-CoV-2 IgM testing for travellers: a private pathology perspective from New South Wales and the Australian Capital Territory, Australia Michael C. Wehrhahn, Gretschen Millan, James P. Newcombe, Matthew Long, Caitlin Keighley, Paul Whiting, Ian Chambers
4 [GO] 2022―Apr―16 Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories Katherine A. Lau, Alexa Kaufer, Joanna Gray, Torsten Theis, William D. Rawlinson
5 [GO] 2022―Feb―10 Clinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA Peter Boan, Andrew Jardine, Todd M. Pryce
6 [GO] 2022―Feb―03 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination Ravin Hettiarachchi, Kartik Naidu, Suzanne Payne, Juliette Holland
7 [GO] 2022―Feb―03 False positive results seen at high CT values with the Xpert Xpress SARS-CoV-2 test Shireen Y.L. Tan, Sui Sin Goh, Kenneth X.L. Chan, James H.C. Sim, Karrie K.K. Ko
8 [GO] 2022―Feb―03 A case of prolonged SARS-CoV-2 viral shedding for 150 days Andrew Fox-Lewis, Shivani Fox-Lewis, Sandra Hotu, Sally Roberts, Gary McAuliffe, Mary De Almeida
9 [GO] 2022―Feb―03 Rapid antigen tests for positive Covid-19 confirmation in the laboratory setting Mikaela Dewar, Anica Pjevalica, Nicholas Clay, Brock Reitzer-Parks, Caitlin L. Keighley
10 [GO] 2022―Feb―03 Management of deaths in temporal relationship to COVID-19 immunisation in NSW Isabel Brouwer, Dianna Inmon, Angela Duncan
11 [GO] 2022―Feb―03 An update on Covid-19 serology Paul M. Kinsella, Theo Karapanagiotidis, Suellen Nicholson, Deborah A. Williamson
12 [GO] 2022―Feb―03 Investigation of deaths following COVID-19 vaccination in Western Australia Kirralee Patton, Leana Downs, Clive Cooke, Jodi White, Victoria Kueppers
13 [GO] 2022―Feb―03 Discordant SARS-CoV-2 RNA results obtained using the Roche cobas liat SARS-CoV-2 Gayle Warnock, Peter Newton
14 [GO] 2022―Feb―03 Severe terminal ileitis following SARS-CoV-2 infection: A histopathological case report Brett Fivelman, Angela Harris
15 [GO] 2022―Feb―03 Airborne transmission of SARS-CoV-2 lineage B.1.617.2 (Delta variant) within a tightly monitored isolation facility Andrew Fox-Lewis, Felicity Williamson, Jay Harrower, Xiaoyun Ren, Gerard J.B. Sonder, Andrea McNeill, et al. (+2)
16 [GO] 2022―Feb―03 De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision Wenxin Hu, Wei Zhao, Amit Kumar, Gurjeet Jagjeet Singh, Shijiao Qi, Josh Casan, et al. (+12)
17 [GO] 2022―Feb―03 SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: A multicentre cross-sectional observational study Andrew Fox-Lewis, Shivani Fox-Lewis, Jenna Beaumont, Dragana Drinković, Jay Harrower, Kevin Howe, et al. (+10)
18 [GO] 2022―Feb―03 An unusual case of heparin-induced thrombocytopenia in a patient infected with SARS-CoV-2 virus Jian Li
19 [GO] 2022―Feb―03 Verification and implementation of a rapid antigen test for SARS-CoV2 detection in clinical settings in Sydney local health district (SLHD) Susy Mathew, John Saunders, Jacquelyn Petty, Rebecca Davis
20 [GO] 2022―Feb―02 Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay Rifky Balgahom, Vishal Ahuja, Catherine Pitman, Adam Polkinghorne, James Branley
21 [GO] 2022―Jan―31 Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant Adriana E. Rosato, Engy Msiha, Bruce Weng, Michael Mesisca, Ronaldo Gnass, Silvia Gnass, et al. (+3)
22 [GO] 2021―Nov―23 Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting Hemalatha Varadhan, Vishal Ahuja, Catherine Pitman, Dominic E. Dwyer
23 [GO] 2021―Nov―08 Cytotoxic CD8 positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis Andrii Puzyrenko, Juan C. Felix, Nathan A. Ledeboer, Yunguang Sun, Hallgeir Rui, Yuri Sheinin
24 [GO] 2021―Nov―06 Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection Riham Abdel-Hamid Haroun, Waleed H. Osman, Rasha E. Amin, Ahmad K. Hassan, Walefed S. Abo-Shanab, Asmaa M. Eessa
25 [GO] 2021―Oct―22 Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay Nicole Isles, Steven G. Badman, Susan Ballard, Bowen Zhang, Benjamin P. Howden, Rebecca Guy, Deborah A. Williamson
26 [GO] 2021―Sep―23 Prolonged PCR positivity in elderly patients infected with SARS-CoV-2 Annaleise R. Howard-Jones, Susan Maddocks, Kerri Basile, Dominic E. Dwyer, James Branley, Jen Kok
27 [GO] 2021―Sep―23 SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers Tasnim Hasan, Hui Lim, Linda Hueston, Dominic E. Dwyer, Matthew O’Sullivan
28 [GO] 2021―Sep―04 Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting Maryza Graham, Stephen Muhi, Tuyet Hoang, Susan A. Ballard, Julie McAuley, Jason C. Kwong, et al. (+2)
29 [GO] 2021―Aug―10 Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience for the Australian context Maryza Graham, Susan A. Ballard, Shivani Pasricha, Belinda Lin, Tuyet Hoang, Timothy Stinear, et al. (+5)
30 [GO] 2021―Jul―20 Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection K.A. Bond, E. Williams, S. Nicholson, S. Lim, D. Johnson, B. Cox, et al. (+10)
31 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and Covid-19 Linda Iles
32 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and covid-19 Linda Iles
33 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and covid-19 Linda Iles
34 [GO] 2021―Jun―24 Clinical forensic medicine and Covid-19 challenges: the melbourne experience Janine Rowse, Nicola Cunningham, Jo Ann Parkin
35 [GO] 2021―Jun―24 Patient blood management - a review of accepted practice; with a focus on optimising patient outcomes during the current COVID-19 pandemic Bryony Ross, Lisa Clarke, Peter Freeman
36 [GO] 2021―Jun―24 COVID-19: 2020 VISION Mike Catton
37 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
38 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and Covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
39 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to sars coronavirus-2 (SARS-CoV-2) and covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
40 [GO] 2021―Jun―24 Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2 Natalie Davidson, Jenny Evans, Jenny Robson
41 [GO] 2021―Jun―24 Expression of GPI-anchored SARS-CoV-2 receptor binding domain in mammalian cells for serological use M.L. Kernich, P.J. Adamson, J.J. Wang, L.P. Kris, B.L. Armour, D. Beroukas, et al. (+4)
42 [GO] 2021―May―18 SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020 Alyson Craigie, Reuben McGregor, Alana L. Whitcombe, Lauren Carlton, David Harte, Michelle Sutherland, et al. (+7)
43 [GO] 2021―Mar―20 SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study Andrew Fox-Lewis, Shivani Fox-Lewis, Jenna Beaumont, Dragana Drinković, Jay Harrower, Kevin Howe, et al. (+10)
44 [GO] 2020―Oct―08 Focus on SARS-CoV-2 and COVID-19 Sharon C-A Chen, William D. Rawlinson
45 [GO] 2020―Oct―08 Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2 T. Gulholm, K. Basile, J. Kok, S.C.-A. Chen, W. Rawlinson
46 [GO] 2020―Oct―08 Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes Gregory Walker, Anupriya Aggarwal, Sonia Underwood, Malinna Yeang, Zin Naing, Alberto Ospina Stella, et al. (+2)
47 [GO] 2020―Oct―05 The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2 P.D. Kirkland, M.J. Frost
48 [GO] 2020―Sep―30 Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low K. Basile, S. Maddocks, J. Kok, D.E. Dwyer
49 [GO] 2020―Sep―30 Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent Alexa M. Kaufer, Torsten Theis, Katherine A. Lau, Joanna L. Gray, William D. Rawlinson
50 [GO] 2020―Sep―30 Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort N. Davidson, J. Evans, D. Giammichele, H. Powell, P. Hobson, B. Teis, et al. (+3)
51 [GO] 2020―Sep―30 Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays Shaun S. Tan, Sharon Saw, Ka Lip Chew, Chan Yiong Huak, Candy Khoo, Anastacia Pajarillaga, et al. (+5)
52 [GO] 2020―Sep―29 Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection? Sergio A.C. Duarte, Jessica G. Pereira, Alexandre Iscaife, Katia R.M. Leite, Alberto A. Antunes
53 [GO] 2020―Sep―22 Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings Brian S.W. Chong, Thomas Tran, Julian Druce, Susan A. Ballard, Julie A. Simpson, Mike Catton
54 [GO] 2020―Sep―22 Clinical evaluation of SARS-CoV-2 point-of-care tests Roselle s. Robosa, Indy Sandaradura, Dominic e. Dwyer, Matthew v.N. O’sullivan
55 [GO] 2020―Sep―21 Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection Kyra Y.L. Chua, Sara Vogrin, Intissar Bittar, Jennifer H. Horvath, Hari Wimaleswaran, Jason A. Trubiano, et al. (+2)
56 [GO] 2020―Sep―01 Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory Eloise Williams, Katherine Bond, Brian Chong, Dawn Giltrap, Malcolm Eaton, Peter Kyriakou, et al. (+7)
57 [GO] 2020―Aug―19 SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings Phoebe C.M. Williams, Annaleise R. Howard-Jones, Peter Hsu, Pamela Palasanthiran, Paul E. Gray, Brendan J. McMullan, et al. (+2)
58 [GO] 2020―Aug―19 Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer Claire Y.T. Wang, Cameron Buckley, Cheryl Bletchly, Patrick Harris, David Whiley
59 [GO] 2020―Aug―12 Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect Kinan Drak Alsibai, Celine Michaud, Alex Taquet, Magalie Demar, Romain Blaizot
60 [GO] 2020―Jul―10 Rapid deployment of pathology services to a remote Australian quarantine setting during the COVID-19 pandemic James Branley, Matthew O’Sullivan, Adam Polkinghorne, Marin Poljak, Dianne Stephens
 [1] 

60 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec